Restoration of SK1 expression through exogenous supplementation with SP1, as in mesenchymal stem cell therapy, inhibits macrophage necroptosis and reduces inflammation in severe AIH models [14]. This evidence concerns the gene SPHK1 and autoimmune hepatitis.